Urology News and Research

Latest Urology News and Research

Watson launches Generess Fe low-dose oral contraceptives in the U.S.

Watson Pharmaceuticals, Inc., today announced the U.S. commercial launch of Generess Fe 0.8 mg/25 mcg, a new low-dose oral contraceptive option that's highly effective at preventing pregnancy and proven to provide users with short, lighter, predictable periods.

2 May 2011

Pediatric urology research papers published in two Elsevier journals

The first World Congress of Pediatric Urology was held in San Francisco in May 2010, bringing together the largest and most successful international congregation of pediatric urologists ever assembled. As part of a collaborative effort, The Journal of Urology and the Journal of Pediatric Urology have together published the landmark papers presented at this meeting.

2 May 2011

Porter Adventist Hospital introduces new institute for robotic surgery

Robotic surgery, once the stuff of science fiction, has for some years been recognized as an important advance in surgical technique and patient experience. Now, at Porter Adventist Hospital, a comprehensive team of surgeons and staff are helping to bring in a new era in robotic surgery.

2 May 2011

Most nurses are chronically sleep deprived

Sleep has become a hot button topic in health care, at least when it comes to physicians. The fact that doctors-in-training don't get enough of it has resulted in regulations governing duty hours in resident training programs across the nation. In 2002, the Accreditation Council of Graduate Medical Education (ACGME) reduced the number of hours that resident physicians can work to 80 hours per week.

30 Apr 2011

USHIFU announces results from clinical investigation of Sonablate HIFU to treat prostate cancer

USHIFU LLC, a world leader in minimally invasive high intensity focused ultrasound technologies and manufacturer of the Sonablate 500 (Sonablate) medical device, announces results from the first-ever prospective clinical investigation of HIFU with the Sonablate to focally treat prostate cancer, a modality in which only the confirmed cancerous regions within the gland are treated as opposed to the entire prostate. Results from the study appear in this month's Journal of Urology.

30 Apr 2011

LSI announces publication of Emerging Medtech Companies report

Life Science Intelligence, a leading medical technology market intelligence firm, has announced the publication of its Report on Emerging Medtech Companies in Q1 2011.

30 Apr 2011

Celgene non-GAAP total revenue increases 40% to $1.11 billion

Celgene Corporation: “The results for the quarter were outstanding and they reflect the ongoing momentum that Celgene is creating as we leverage our business model and position our Company for long-term success”.

28 Apr 2011

UCLA's Kidney and Pancreas Transplant Program improves patients' survival rate

Patients who received kidney transplants through the UCLA Kidney and Pancreas Transplant Program had the highest three-year transplant survival rate among patients who underwent the procedure at U.S. centers that perform 80 or more transplants a year, according to new government data.

28 Apr 2011

Five Loyola employees donate kidneys to complete strangers

Loyola University Medical Center is believed to be the first organization in the country, and perhaps the world, in which five employees have each donated kidneys to complete strangers with no strings attached.

28 Apr 2011

Watson reports net revenue of $876.5 million for first quarter 2011

Watson Pharmaceuticals, Inc. today reported net revenue of $876.5 million for the first quarter ended March 31, 2011, compared to $856.5 million in the first quarter 2010.

27 Apr 2011

Columbia requests FDA Priority Review for PROCHIEVE progesterone gel NDA

Columbia Laboratories, Inc., and Watson Pharmaceuticals, Inc., today announced that Columbia has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for PROCHIEVE® (progesterone gel) for the reduction of risk of preterm birth in women with short uterine cervical length in the mid-trimester of pregnancy.

27 Apr 2011

Teleflex first quarter net revenue increases 6% to $388.7 million

Teleflex Incorporated, a leading, global provider of medical technology products, today reported financial results for the three months ended March 27, 2011.

26 Apr 2011

Uroplasty to present Urgent PC, Macroplastique products study data at upcoming meetings

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that the results of clinical studies using Uroplasty's Urgent PC Neuromodulation System and Macroplastique urethral bulking agent products are scheduled to be presented at three upcoming professional meetings.

25 Apr 2011

Urologic Nursing publishes NAFC nocturia research in middle-aged American women

Research by the National Association For Continence about nocturia in middle-aged American women appears in the current issue of Urologic Nursing, the official journal of the Society of Urologic Nurses and Associates.

22 Apr 2011

Watson Laboratories seeks FDA approval to market Colesevelam HCI tablets

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market Colesevelam HCI 625 mg tablets.

21 Apr 2011

Testosterone therapy for prostate cancer needs reevaluation: New study

The long-standing prohibition against testosterone therapy in men with untreated or low-risk prostate cancer merits reevaluation, according to a new study published in The Journal of Urology.

20 Apr 2011

Squamous cell cancers can originate from hair follicle stem cells, finds study

Squamous cell cancers, which can occur in multiple organs in the body, can originate from hair follicle stem cells, a finding that could result in new strategies to treat and potentially prevent the disease, according to a study by researchers with UCLA's Jonsson Comprehensive Cancer Center and the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA.

20 Apr 2011

New biomarker-based test more effective for early acute kidney injury detection

A new biomarker-based diagnostic test is more effective than the current best practice for early detection of adverse outcomes after acute kidney injury, which can be fatal for an estimated 50 percent of the critically ill patients who get the condition.

19 Apr 2011

Drospirenone doesn't carry any risk of gall bladder disease

Drospirenone, the top-selling oral contraceptive marketed as Yaz or Yasmin in the U.S. and Canada, doesn't carry any more risk of gall bladder disease than the older generation of birth control pills, despite claims by some consumers and lawyers in both countries, according to a new study by University of British Columbia and Vancouver Coastal Health Research Institute researcher Mahyar Etminan.

19 Apr 2011

Nerve disorder expert Jack Griffin passes away

Jack Griffin, an internationally acclaimed and admired expert on diseases of the peripheral nervous system, founding director of the Johns Hopkins Brain Science Institute, and former director of Hopkins School of Medicine's Department of Neurology, died Saturday, April 16, after a long battle with bladder cancer. He was 69.

18 Apr 2011